| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/21/2008 | US20080044884 Method and device for separating cells from a sample using a nonplanar solid substrate |
| 02/21/2008 | US20080044807 Method of Detecting Hepatitis C Virus |
| 02/21/2008 | US20080044438 Yeast Cell Particles As Oral Delivery Vehicles For Antigens |
| 02/21/2008 | US20080044427 Plant virus |
| 02/21/2008 | US20080044426 Novel Atypical Pneumonia-Causing Virus |
| 02/21/2008 | US20080044384 Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens |
| 02/21/2008 | CA2661296A1 Development of dengue virus vaccine components |
| 02/21/2008 | CA2659267A1 Influenza hemagglutinin and neuraminidase variants |
| 02/20/2008 | EP1888621A2 Porcine circovirus type 2 vaccines |
| 02/20/2008 | EP1492891B1 Methods of virus production |
| 02/20/2008 | EP1385370B1 Animicrobial polypeptides and their uses |
| 02/20/2008 | EP0907746B1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/20/2008 | CN101128478A N protein mutants of porcine reproductive and respiratory syndrome virus |
| 02/20/2008 | CN100370023C Process for reproducing virus of large brill hemorrhagic septicaemia by large brill fin clone |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | US7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/19/2008 | US7332333 Host cells containing multiple integrating vectors |
| 02/19/2008 | US7332322 Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof |
| 02/19/2008 | US7332321 Fabricating wet spun or electrospun fibers using nanometer scale liquid crystalline viral particle suspensions where particle composition and function can be modified genetically to include binding or nucleating conjugate moieties while maintaining fibrous structure end product |
| 02/19/2008 | US7332307 Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system |
| 02/19/2008 | US7332269 Hepatitis C virus (HCV) diagnosis kits wherein ability of proteins to bind anti-HCV murine antibodies has been removed; solid phase synthesis |
| 02/19/2008 | US7332176 Solenopsis invicta viruses |
| 02/19/2008 | US7332169 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine |
| 02/19/2008 | CA2171699C Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
| 02/14/2008 | WO2008017870A1 Attenuated polio viruses |
| 02/14/2008 | US20080039528 Zinc finger ejectors and methods of use thereof |
| 02/14/2008 | US20080038822 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/14/2008 | US20080038717 Enrichment method for variant proteins with altered binding properties |
| 02/14/2008 | US20080038716 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | CA2660375A1 Attenuated polioviruses |
| 02/13/2008 | EP1885847A2 Scalable fermentation process |
| 02/13/2008 | EP1885394A2 Production of multivalent virus like particles |
| 02/13/2008 | EP1554401B1 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 02/13/2008 | EP1292328B1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 02/13/2008 | EP1185663B1 Novel gbv sequence |
| 02/13/2008 | EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 02/13/2008 | CN201020070Y Full-automatic self-plasma virus deactivation therapeutic equipment |
| 02/13/2008 | CN101124328A Chimeric vectors |
| 02/13/2008 | CN101123871A Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 02/13/2008 | CN101121938A Method for preparing foot-and-mouth disease antigen |
| 02/12/2008 | US7329725 For discovering peptide ligands that bind to and antagonize disease-associated receptors or ligands |
| 02/12/2008 | US7329530 Chimaeric phages |
| 02/12/2008 | US7329509 Culturing a host infected with recombinant baculovirus; co-expressing interacting protein, membrane-bound receptor protein in a budded baculovirus released from host |
| 02/12/2008 | US7329498 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
| 02/12/2008 | US7329409 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections |
| 02/12/2008 | US7329407 Recombinant herpesvirus and polyvalent vaccine |
| 02/12/2008 | CA2116500C Canine coronavirus vaccine from feline enteric coronavirus |
| 02/07/2008 | US20080032379 Pyrenyloxysulfonic acid flurescent agents |
| 02/07/2008 | US20080032279 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 02/07/2008 | US20080031886 Viruses for the treatment of cellular proliferative disorders |
| 02/07/2008 | US20080031856 Solenopsis invicta virus |
| 02/07/2008 | US20080031853 treating Hepatitis-C virus; covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides |
| 02/07/2008 | US20080031852 inhibitor of HCV NS5B polymerase; to treat infections caused by hepatitis C virus; 3-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methyl-butyl)-pyrrolo[1,2-b]pyridazin-2-one |
| 02/06/2008 | CN101117627A Pig epidemic diarrhea virus attenuated vaccine strain and uses thereof |
| 02/05/2008 | US7326555 Using domiphen bromide to selectively precipitate viral particles from DNA mixtures; ion echange chromatography |
| 01/31/2008 | WO2008013276A1 Therapeutic agent for malignant mesothelioma |
| 01/31/2008 | WO2007143545A3 Tnf signaling in myxoma virus treatments |
| 01/31/2008 | WO2007084499A8 Disease control in shrimp |
| 01/31/2008 | US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family |
| 01/31/2008 | US20080026449 Infectious Bronchitis Virus Vaccine |
| 01/31/2008 | US20080026448 Production of HIV |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026048 Reovirus for the treatment of cellular proliferative disorders |
| 01/31/2008 | US20080026004 Membrane virus host range mutations and their uses as vaccine substrates |
| 01/31/2008 | CA2659262A1 Improved vaccines and methods for using the same |
| 01/30/2008 | EP1882738A1 Methods for recovering microorganism and nucleic acid using fine particle and kit to be used for the methods |
| 01/30/2008 | EP1882032A2 Gammaretrovirus associated with cancer |
| 01/30/2008 | EP0972063B1 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/30/2008 | CN101115830A Method of retrovirus storage |
| 01/29/2008 | US7323623 Molecules encoding defensive polypeptides; enhancing disease resistance of a plant to a fungal pathogen; vectors, expression cassettes, viruses, cells, and plants |
| 01/29/2008 | US7323177 delivery vectors for antigen producing genes (heterologous gene sequences or fragments thereof) used to generate immune responses in commercial pigs; recombinant porcine adenovirus capable of expressing DNA of interest |
| 01/24/2008 | WO2008011636A2 Targeted gene delivery for dendritic cell vaccination |
| 01/24/2008 | WO2007137267A3 Protein production using eukaryotic cell lines |
| 01/24/2008 | WO2007117303A3 Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| 01/24/2008 | WO2007067856A3 A method for the inactivation and removal of dengue virus from biological samples |
| 01/24/2008 | WO2007049265A3 Anti mineralocorticoid therapy of infection |
| 01/24/2008 | WO2006101841A3 Seneca valley virus based compositions and methods for treating disease |
| 01/24/2008 | US20080021207 Recoded bovine immunodeficiency virus sequence comprising preferred human codons; use in gene delivery |
| 01/24/2008 | US20080020992 MULTICISTRONIC CONSTRUCTS WITH siRNA TO INHIBIT TUMORS |
| 01/24/2008 | US20080019998 Targeted gene delivery for dendritic cell vaccination |
| 01/24/2008 | US20080019991 Carrier Conjugates Of Tnf-Peptides |
| 01/24/2008 | US20080019981 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 01/24/2008 | US20080019980 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 01/24/2008 | US20080019945 Attenuation of Cytomegalovirus Virulence |
| 01/24/2008 | CA2659032A1 Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/23/2008 | EP1881075A1 Retroviral vectors having a reduced recombination rate |
| 01/23/2008 | EP1881072A1 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initation factor 5A, transgenic plants and a method for controlling senescene and programmed cell death in plants |
| 01/23/2008 | EP1880006A2 Primate t-lymphotropic viruses |
| 01/23/2008 | EP1601772B1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
| 01/23/2008 | EP1465987B1 Production of viruses, viral isolates and vaccines |
| 01/23/2008 | EP1268748B1 Method of producing adenoviral vector stocks |
| 01/23/2008 | EP1240310B1 Method of inactivating microorganisms |
| 01/23/2008 | EP1141315B1 Modified hiv env polypeptides |
| 01/23/2008 | CN100363489C An imine-resistant bacillus pyocyaneus bacteriophage and its use for treating infection therefrom |
| 01/22/2008 | US7321030 Tumor-specific promotor and use thereof |
| 01/22/2008 | US7320888 Submergence-induced protein-like factors |
| 01/22/2008 | US7320857 Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof |
| 01/22/2008 | CA2408251C Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/22/2008 | CA2380569C Chimeric polypeptides, method for production and uses thereof |